分子生物学
IVD分子诊断
细胞培养与分析
蛋白研究
细胞因子
重组蛋白
抗体
高通量测序建库
病原检测UCF系列
生物医药
工具酶
抑制剂激活剂与常用试剂
仪器
耗材

CD98hc controls CNS angiogenesis and blood–brain barrier integrity through localized regulation of the systemic integrin–FAK pathway

Hu Xiaoyan, Yu Min, Yang Shilun, Fang Cheng, Wei Pengju, Zhang Xun, Ma Yinzhong, Feng Ziying, Chen Yukun, Yan Jingyu, Wang Ying, Qiu Linhui, Song Dengpan, Guo Fuyou, Chang Junlei

Journal:Nature Cardiovascular Research

IF:12.6

DOI:10.1038/s44161-026-00816-4

PMID:42120583

Published:2026-05-12

research field:神经科学血管生物学分子生物学

Abstract

Normal vascular structure and function are crucial for the homeostasis of the central nervous system (CNS), yet the regulation of CNS vasculature remains incompletely understood. Here we show that CD98 heavy chain (CD98hc), also known as SLC3A2 or 4F2hc, is essential for CNS angiogenesis and blood–brain barrier (BBB) integrity. CD98hc is selectively enriched in the CNS endothelium versus the peripheral endothelium in mice and humans. Ablation of endothelial CD98hc in mouse embryos leads to aberrant CNS angiogenesis, impaired BBB formation and cerebral hemorrhage, without affecting the peripheral vasculature. In adults, endothelial CD98hc deficiency does not impact homeostatic CNS angiogenesis but disrupts the BBB and causes neurological deficits. The mechanism involves a CNS-specific reduction in the systemic integrin–FAK pathway in endothelial cells, affecting subsequent VEGFR2 and Wnt–β-catenin pathways. Importantly, FAK activation fully rectifies the CNS vascular phenotype in CD98hc-deficient mice. These findings open promising avenues for CNS-specific vascular regulation and targeted therapy of cerebrovascular diseases.

本文使用的Yeasen产品

购物车
客服
转染试用